Roivant Sciences (ROIV) Short term Debt (2022 - 2024)

Roivant Sciences (ROIV) has 3 years of Short term Debt data on file, last reported at $12.0 million in Q2 2024.

• Quarterly Short term Debt rose 63.4% year-over-year to $12.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $12.0 million (up 63.4% YoY) and the FY2024 annual result came in at $12.0 million, down 70.53% from the prior year.
• Short term Debt was little changed at $12.0 million in Q2 2024, from $12.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $49.0 million in Q3 2023 to a low of $7.3 million in Q2 2022.
• A 3-year average of $20.8 million and a median of $14.7 million in 2022 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2023 — Short term Debt soared 233.61% — and 2024, when it tumbled 70.53%.
• Tracing ROIV's Short term Debt over 3 years: stood at $22.0 million in 2022, then changed by 0.0% to $22.0 million in 2023, then slumped by 45.53% to $12.0 million in 2024.
• The last three Short term Debt figures came in at $12.0 million (Q2 2024), $12.0 million (Q1 2024), and $22.0 million (Q4 2023), per Business Quant data.